Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

pounds 684m Gehe bid could clinch Lloyds battle

Magnus Grimond
Friday 10 January 1997 19:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Gehe, the German pharmaceuticals distributor, yesterday looked close to clinching the 12-month bid battle for Lloyds Chemists after raising its all-cash offer to pounds 684m.

The bidder moved into the market to scoop up just under 21 per cent of Lloyds' shares soon after the announcement that the offer was being raised from 500p to 525p a share and made final.

The move comes a week before the final deadline for higher offers, but Dieter Kammerer, Gehe chairman, said the delay was damaging the business. Since the start of the bid last January, Gehe estimated the value of Lloyds had declined by around 10 per cent. Adding that back to the revised terms, would value them at more like 560p to 570p a share, he claimed. There was no word from rival bidder UniChem yesterday but analysts said it would be difficult for it to top Gehe's terms.

Shares in Lloyds jumped 14p to 526.5p, but UniChem's were also 10p higher at 256p on expectations that it would not increase its offer. If UniChem does bow out, directors could make pounds 4.3m in option profits and pay-offs, while the stake belonging to Allen Lloyd, chairman, could be worth pounds 32m.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in